Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
HPRA MIMS Articles April 2020
Notice type:
3rd Party Publications
Date:
07/04/2020
Selective Serotonin Reuptake Inhibitors (SSRI) and Serotonin–Norepinephrine Reuptake Inhibitors (SNRI) – Persistent sexual dysfunction after drug withdrawal
Suspension of marketing authorisation for ingenol mebutate (Picato▼) as a precaution while review of skin cancer risk continues
« Back
Date Printed: 23/04/2024